Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibodies
Pharma
FDA probes safety of Takeda's Adzynma after reported death
The FDA has opened an investigation into Takeda’s recombinant protein med Adzynma after the reported death of a pediatric patient who took the drug.
Fraiser Kansteiner
Nov 21, 2025 11:40am
Samsung adds to BMS partnership with $242M antibody agreement
Sep 18, 2023 10:50am
Danaher to buy antibody expert Abcam for $5.7B
Aug 28, 2023 9:18am
England's Abcam weighs its options, which could include a sale
Jun 29, 2023 8:05am
Nasal delivery gets antibody to rodent brains to treat stroke
Jan 24, 2023 6:40am
Argenx builds clinical case for 'pipeline in a product' efgart
Dec 10, 2022 11:30am
